Lotus Eye Hospital P/E Ratio
Current P/E Ratio
1587.86
High Valuation
Very High - High growth expectations or significantly overvalued
Lotus Eye Hospital (LOTUSEYE) P/E ratio is 1587.86 (High), EPS (TTM) ₹0.04, current price ₹115.10 on NSE — Very High - High growth expectations or significantly overvalued. Also explore Lotus Eye Hospital stock price data download to track price trends across different timeframes.
Current Valuation Metrics
P/E Ratio
1587.86
Current Price
₹115.10
EPS (TTM)
₹0.04
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
68.5
Sector Median
40.77
Sector Rank
#11 of 57
Sector Percentile
19.3%
LOTUSEYE P/E Ratio — Valuation Signal & Historical Context
Lotus Eye Hospital P/E 1587.86 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see LOTUSEYE stock price BSE.
- Stock appears overvalued with PE of 1587.86, suggesting caution for new investments
- Trading at premium to sector average PE of 68.5
LOTUSEYE vs Healthcare Services Peers — P/E Ratio Comparison
Lotus Eye Hospital P/E 1587.86 vs Healthcare Services average 68.5, median 40.77 — range 7.19–644.14.
Sector Average
68.5
Sector Median
40.77
Lowest P/E
7.19
Highest P/E
644.14
Companies
57
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 7.19 | ₹135 | Low |
| Abate AS Industries | ABATEAS | 11.13 | ₹134 | Low |
| Deccan Health Care | DECCAN | 12.09 | ₹31 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.27 | ₹19 | Low |
| One Global Service Provi… | ONEGLOBAL | 14.36 | ₹1,056 | Low |
| Shanmuga Hospital | SHANMUGA | 15.88 | ₹67 | Moderate |
| Invicta Diagnostic | INVICTA | 17.27 | ₹82 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 17.55 | ₹3,254 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 18.39 | ₹1,757 | Moderate |
| Chandan Healthcare | CHANDAN | 18.55 | ₹500 | Moderate |